斑塊旋切術設備市場：依細分市場劃分的規模、佔有率、法規、償付、程序、到2033年的預測

斑塊旋切術是一種去除血管斑塊的微創手術。斑塊旋切術對於去除高度鈣化的斑塊特別有用。斑塊切除術用於清除冠狀動脈和周邊血管的阻塞並恢復血流。斑塊切除術也可以與血管成形術或支架置入術結合。

冠狀動脈疾病（CAD）是指因心肌供血和供氧不足而導致冠狀動脈狹窄。週邊動脈疾病（PAD）的特徵是下肢動脈粥狀硬化斑塊積聚，這會干擾正常血流並導致神經和組織損傷。這些疾病在已開發國家的高盛行率以及新的和改進的診斷方法的開發有助於提高使用微創手術（例如血管成形術、支架置入術和斑塊切除術）的治療率。這些治療已成為 PAD 患者的首選治療方法，取代了侵入性動脈繞道手術。

本報告深入探討了全球旋切設備市場，包括競爭格局、SWOT 分析、到2033年的市場預測以及區域和國家趨勢。

目錄

目前市面上的旋切設備及競爭狀況

• 對主要產業趨勢的見解
• 2015年至2033年依細分市場劃分的斑塊旋切設備市場總收入及市場前景
• 依細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細資料

全球、區域與國家見解

• 旋切設備市場的 SWOT 分析
• 斑塊切除設備市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 依國家/地區劃分的償付政策
• 各國醫療科技的監管狀況

Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

Atherectomy is a minimally invasive procedure that removes plaque from vessels. Atherectomy is especially valuable in eliminating highly calcified plaque. Atherectomy procedure may be used for coronary and peripheral vessels to open a blockage and restore blood flow. The atherectomy may be combined with angioplasty and stenting.

Coronary Artery Disease (CAD) refers to narrowing of the coronary arteries due to inadequate supply of blood and oxygen to cardiac muscles. Peripheral artery disease (PAD) is characterized by the build-up of atherosclerotic plaque in the lower extremities, which disturbs normal blood flow and can cause nerve and tissue damage. The high prevalence of these disease in the developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally-invasive techniques, such as angioplasty, stenting, and atherectomy. These procedures have replaced invasive artery bypass surgery as the first line of treatment for patients with PAD.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Atherectomy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Atherectomy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Atherectomy Devices market.
• Competitive dynamics insights and trends provided for Atherectomy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Cardiovascular Systems Inc, Boston Scientific Corp, Koninklijke Philips NV, Medtronic Plc, Avinger Inc, Becton Dickinson and Co, Angiodynamics Inc.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Atherectomy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Atherectomy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Atherectomy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Atherectomy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.